High-dose therapy and autologous stem cell transplantation versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy: long-term results

被引：23

作者：

Carella, Angelo Michele ^{[1
]}

Bellei, Monica ^{[2
]}

Brice, Pauline ^{[3
]}

Gisselbrecht, Christian ^{[3
]}

Visani, Giuseppe ^{[4
]}

Colombat, Philippe ^{[5
]}

Fabbiano, Francesco ^{[6
]}

Donelli, Amedea ^{[2
]}

Luminari, Stefano ^{[2
]}

Feugier, Pierre ^{[7
]}

Browett, Peter ^{[8
]}

Hagberg, Hans ^{[9
,10
,11
]}

Federico, Massimo ^{[2
]}

机构：

[1] AOU San Martino, Div Ematol, I-16132 Genoa, Italy

[2] Univ Modena, Dip Oncol & Ematol, I-41100 Modena, Italy

[3] Hop St Louis, Inst Hematol, Paris, France

[4] Osped San Salvatore, Div Ematol, Pesaro, Italy

[5] Ctr Hop Bretonneau, Serv Oncol Med & Malad Sang, Tours, France

[6] Osped Cervello, Div Ematol, Palermo, Italy

[7] Univ Hosp Nancy, Dep Hemato Internal Med, Nancy, France

[8] Univ Auckland, Lab Med, Auckland 1, New Zealand

[9] Uppsala Univ, Dept Oncol, Uppsala, Sweden

[10] Uppsala Univ, Dept Radiol, Uppsala, Sweden

[11] Uppsala Univ, Dept Clin Immunol, Uppsala, Sweden

来源：

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2009年 / 94卷 / 01期

关键词：

PROGNOSTIC SCORE; CHEMOTHERAPY; DISEASE; RISK;

D O I：

10.3324/haematol.13484

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：146 / 148

页数：3

共 8 条

[1]

André M, 1998, BLOOD, V92, P1933

[2]

CARELLA AM, 1991, BONE MARROW TRANSPL, V8, P99

[3] High-dose therapy and autologous stem-cell transplantation versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy [J].

Federico, M ;

Bellei, M ;

Brice, P ;

Brugiatelli, M ;

Nagler, A ;

Gisselbrecht, C ;

Moretti, L ;

Colombat, P ;

Luminari, S ;

Fabbiano, F ;

Di Renzo, N ;

Goldstone, A ;

Carella, AM .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (12) :2320-2325

[4] Early interim 2-[18F]Fluoro-2-Deoxy-D-Glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma:: A report from a joint Italian-Danish study [J].

Gallamini, Andrea ;

Hutchings, Martin ;

Rigacci, Luigi ;

Specht, Lena ;

Merli, Francesco ;

Hansen, Mads ;

Patti, Caterina ;

Loft, Annika ;

Di Raimondo, Francesco ;

D'Amore, Francesco ;

Biggi, Alberto ;

Vitolo, Umberto ;

Stelitano, Caterina ;

Sancetta, Rosario ;

Trentin, Livio ;

Luminari, Stefano ;

Iannitto, Emilio ;

Viviani, Simonetta ;

Pierri, Ivana ;

Levis, Alessandro .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (24) :3746-3752

[5]

Gallamini A, 2006, HAEMATOLOGICA, V91, P475

[6] A prognostic score for advanced Hodgkin's disease [J].

Hasenclever, D ;

Diehl, V .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (21) :1506-1514

[7] FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma [J].

Hutchings, M ;

Loft, A ;

Hansen, M ;

Pedersen, LM ;

Buhl, T ;

Jurlander, J ;

Buus, S ;

Keiding, S ;

D'Amore, F ;

Boesen, AM ;

Berthelsen, AK ;

Specht, L .

BLOOD, 2006, 107 (01) :52-59

[8] PROGNOSTIC FACTORS AMONG 185 ADULTS WITH NEWLY DIAGNOSED ADVANCED HODGKINS-DISEASE TREATED WITH ALTERNATING POTENTIALLY NONCROSS-RESISTANT CHEMOTHERAPY AND INTERMEDIATE-DOSE RADIATION-THERAPY [J].

STRAUS, DJ ;

GAYNOR, JJ ;

MYERS, J ;

MERKE, DP ;

CARAVELLI, J ;

CHAPMAN, D ;

YAHALOM, J ;

CLARKSON, BD .

JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (07) :1173-1186

← 1 →